Free Trial

Genpact (G) Financials

Genpact logo
$33.90 -0.18 (-0.53%)
Closing price 05/6/2026 03:59 PM Eastern
Extended Trading
$34.14 +0.24 (+0.72%)
As of 05/6/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Genpact

Annual Income Statements for Genpact

This table shows Genpact's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
240 270 263 564 305 308 369 353 631 514 552
Consolidated Net Income / (Loss)
240 268 261 563 305 308 369 353 631 514 552
Net Income / (Loss) Continuing Operations
240 268 261 281 305 308 369 353 631 514 552
Total Pre-Tax Income
302 330 321 362 399 400 483 465 602 677 730
Total Operating Income
334 341 331 348 429 439 509 502 631 702 750
Total Gross Profit
967 1,016 1,055 1,079 1,226 1,291 1,432 1,536 1,571 1,690 1,831
Total Revenue
2,461 2,571 2,737 3,001 3,521 3,709 4,022 4,371 4,477 4,767 5,080
Operating Revenue
2,461 2,571 2,737 3,001 3,521 3,709 4,022 4,371 4,477 4,767 5,080
Total Cost of Revenue
1,494 1,554 1,681 1,922 2,295 2,418 2,590 2,835 2,906 3,077 3,249
Operating Cost of Revenue
1,494 1,554 1,681 1,922 2,295 2,418 2,590 2,835 2,906 3,077 3,249
Total Operating Expenses
633 675 724 731 796 853 923 1,034 940 988 1,081
Selling, General & Admin Expense
608 653 689 694 795 790 866 938 913 967 1,047
Amortization Expense
29 27 36 39 33 43 58 43 31 26 24
Other Operating Expenses / (Income)
-3.32 -4.94 -1.66 -1.85 -31 19 -1.20 53 -4.72 -5.62 9.80
Total Other Income / (Expense), net
-32 -12 -11 14 -30 -38 -26 -37 -29 -25 -20
Interest & Investment Income
-42 -24 -36 -37 -43 -49 -51 -52 -48 -47 -50
Other Income / (Expense), net
9.63 12 26 51 14 11 26 15 19 22 30
Income Tax Expense
62 62 60 81 95 92 114 112 -29 163 178
Basic Earnings per Share
$1.11 $1.30 $1.36 $1.48 $1.60 $1.62 $1.97 $1.92 $3.46 $2.88 $3.18
Weighted Average Basic Shares Outstanding
216.61M 206.86M 193.86M 190.67M 190.07M 190.40M 187.80M 184.18M 182.35M 178.39M 173.89M
Diluted Earnings per Share
$1.09 $1.28 $1.34 $1.45 $1.56 $1.57 $1.91 $1.88 $3.41 $2.85 $3.13
Weighted Average Diluted Shares Outstanding
219.15M 210.13M 197.05M 193.98M 195.16M 195.78M 192.96M 188.09M 185.14M 180.44M 176.65M
Weighted Average Basic & Diluted Shares Outstanding
216.10M 207.40M 193.50M 190.60M 190.40M 188.14M 185.17M 183.98M 180.73M 175.67M 169.86M
Cash Dividends to Common per Share
- $0.00 $0.24 $0.30 $0.34 $0.39 $0.11 $0.13 $0.55 $0.61 $0.68

Quarterly Income Statements for Genpact

This table shows Genpact's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
116 118 291 117 122 133 142 131 133 146 143
Consolidated Net Income / (Loss)
116 118 291 117 122 133 142 131 133 146 143
Net Income / (Loss) Continuing Operations
116 118 291 117 122 133 142 131 133 146 143
Total Pre-Tax Income
150 155 158 156 162 175 183 175 177 189 189
Total Operating Income
157 166 163 160 170 182 190 184 179 192 195
Total Gross Profit
390 403 408 396 416 431 446 429 450 470 482
Total Revenue
1,106 1,136 1,146 1,131 1,176 1,211 1,249 1,215 1,254 1,291 1,319
Operating Revenue
1,106 1,136 1,146 1,131 1,176 1,211 1,249 1,215 1,254 1,291 1,319
Total Cost of Revenue
715 733 739 735 760 780 803 786 804 822 837
Operating Cost of Revenue
715 733 739 735 760 780 803 786 804 822 837
Total Operating Expenses
233 237 245 236 246 250 256 245 271 278 287
Selling, General & Admin Expense
229 230 237 235 240 243 249 241 266 262 277
Amortization Expense
8.26 7.50 7.45 6.93 6.56 6.50 6.50 4.32 4.32 8.29 7.37
Other Operating Expenses / (Income)
-4.96 -0.09 -0.05 -5.47 -0.07 -0.02 -0.06 -0.11 -0.04 7.62 2.33
Total Other Income / (Expense), net
-6.95 -11 -4.26 -3.62 -7.83 -6.16 -7.63 -8.48 -2.66 -2.29 -6.63
Interest & Investment Income
-12 -13 -13 -10 -14 -12 -11 -11 -13 -13 -12
Other Income / (Expense), net
5.19 2.47 8.66 6.62 5.70 6.22 3.42 2.97 11 10 5.25
Income Tax Expense
34 37 -133 39 40 43 41 44 44 44 46
Basic Earnings per Share
$0.63 $0.65 $1.60 $0.65 $0.68 $0.75 $0.80 $0.75 $0.76 $0.84 $0.83
Weighted Average Basic Shares Outstanding
183.23M 181.40M 182.35M 180.42M 179.65M 177.60M 178.39M 175.53M 174.61M 173.58M 173.89M
Diluted Earnings per Share
$0.63 $0.64 $1.57 $0.64 $0.67 $0.74 $0.80 $0.73 $0.75 $0.83 $0.82
Weighted Average Diluted Shares Outstanding
185.83M 183.80M 185.14M 181.94M 180.91M 179.71M 180.44M 178.44M 177.05M 176.10M 176.65M
Weighted Average Basic & Diluted Shares Outstanding
181.32M 181.41M 180.73M 179.98M 178.18M 176.36M 175.67M 174.87M 174.27M 172.41M 169.86M

Annual Cash Flow Statements for Genpact

This table details how cash moves in and out of Genpact's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
8.08 -13 44 -72 110 226 239 -164 -71 85 211
Net Cash From Operating Activities
327 346 359 340 428 584 694 444 491 615 813
Net Cash From Continuing Operating Activities
327 346 359 341 428 584 694 444 491 615 813
Net Income / (Loss) Continuing Operations
240 268 261 283 305 308 369 353 631 514 552
Consolidated Net Income / (Loss)
240 268 261 281 305 308 369 353 631 514 552
Depreciation Expense
54 55 59 65 96 116 109 87 73 70 71
Amortization Expense
42 29 38 43 34 46 61 45 33 29 27
Non-Cash Adjustments To Reconcile Net Income
37 -15 9.64 -17 -14 20 160 138 55 -6.86 -44
Changes in Operating Assets and Liabilities, net
-46 10 -8.20 -33 6.25 94 -5.54 -180 -301 9.94 207
Net Cash From Investing Activities
-100 -126 -362 -276 -357 -266 -123 -37 -79 -106 -495
Net Cash From Continuing Investing Activities
-100 -126 -362 -276 -357 -266 -123 -37 -79 -106 -495
Purchase of Property, Plant & Equipment
-62 -82 -57 -85 -75 -70 -53 -51 -55 -83 -78
Acquisitions
-40 -62 -306 -187 -34 -197 -76 -3.81 -4.04 -2.47 -91
Purchase of Investments
- - - - - - - 0.00 0.00 -23 -350
Sale of Property, Plant & Equipment
1.49 0.55 1.74 0.67 1.75 0.61 6.38 0.06 0.03 2.64 0.06
Divestitures
- 17 - 0.00 -250 0.00 0.14 18 -20 0.00 0.00
Sale and/or Maturity of Investments
- - - - - - - - 0.00 0.00 23
Net Cash From Financing Activities
-219 -233 47 -135 40 -92 -333 -571 -483 -425 -107
Net Cash From Continuing Financing Activities
-219 -233 47 -135 40 -92 -333 -571 -483 -425 -107
Repayment of Debt
-2,258 -103 -328 -295 -661 -475 -301 -746 -321 -509 -125
Repurchase of Preferred Equity
- - -0.02 - - - - - -225 -253 -283
Payment of Dividends
- - -47 -57 -65 -74 -80 -92 -100 -108 -118
Issuance of Debt
2,252 200 645 379 800 610 350 500 148 450 435
Issuance of Common Equity
16 18 16 14 20 25 35 28 39 17 18
Other Financing Activities, net
-0.86 -2.25 -19 -22 -24 -41 -38 -47 -24 -22 -33
Cash Interest Paid
21 20 28 41 45 49 46 51 48 69 60
Cash Income Taxes Paid
72 47 66 81 104 194 32 146 157 114 144

Quarterly Cash Flow Statements for Genpact

This table details how cash moves in and out of Genpact's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Net Change in Cash & Equivalents
-57 67 28 -98 440 98 -355 -84 91 80 124
Net Cash From Operating Activities
171 162 192 -26 209 228 203 40 177 308 287
Net Cash From Continuing Operating Activities
171 162 192 -26 209 228 203 40 177 308 287
Net Income / (Loss) Continuing Operations
116 118 291 117 122 133 142 131 133 146 143
Consolidated Net Income / (Loss)
116 118 291 117 122 133 142 131 133 146 143
Depreciation Expense
18 18 18 17 17 17 18 17 17 18 19
Amortization Expense
8.75 7.99 7.95 7.42 7.11 7.21 7.16 4.87 4.87 8.85 8.04
Non-Cash Adjustments To Reconcile Net Income
-24 -23 92 -8.95 19 36 -53 6.56 -13 29 -68
Changes in Operating Assets and Liabilities, net
52 42 -218 -158 44 35 89 -119 35 106 184
Net Cash From Investing Activities
-12 -14 -19 -25 -20 -20 -41 0.78 -105 -19 -372
Net Cash From Continuing Investing Activities
-12 -14 -19 -25 -20 -20 -41 0.78 -105 -19 -372
Purchase of Property, Plant & Equipment
-11 -13 -18 -24 -19 -20 -20 -22 -22 -16 -18
Acquisitions
-0.88 -0.86 19 -0.67 -0.59 -0.53 -0.68 -0.60 -83 -2.90 -4.20
Sale of Property, Plant & Equipment
0.01 0.00 0.00 - 0.12 0.01 2.51 - - 0.03 0.00
Net Cash From Financing Activities
-216 -81 -145 -48 251 -110 -517 -126 19 -209 209
Net Cash From Continuing Financing Activities
-216 -81 -145 -48 251 -110 -517 -126 19 -209 209
Repayment of Debt
-160 -57 -48 -27 -62 -10 -410 -8.97 -8.76 -94 -14
Repurchase of Preferred Equity
-121 - - -30 -63 -75 - -63 -30 -90 -100
Payment of Dividends
-25 -25 -25 -27 -27 -27 -27 -30 -30 -29 -29
Issuance of Debt
73 - - 50 400 - - 0.00 85 - 350
Issuance of Common Equity
16 2.71 4.85 6.80 2.92 2.45 5.05 6.94 2.40 5.00 3.16
Other Financing Activities, net
-0.15 -1.37 -1.84 -21 -0.32 -0.17 -0.97 -31 -0.13 -0.96 -1.55
Cash Interest Paid
16 9.00 16 11 19 8.56 30 7.15 23 7.78 22
Cash Income Taxes Paid
44 57 33 20 26 32 36 21 31 47 45

Annual Balance Sheets for Genpact

This table presents Genpact's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
2,793 2,886 3,450 3,529 4,454 4,874 4,975 4,589 4,806 4,987 5,843
Total Current Assets
1,195 1,227 1,434 1,355 1,552 1,749 1,922 1,779 1,892 2,080 2,656
Cash & Equivalents
451 423 504 368 467 680 899 647 584 648 854
Short-Term Investments
- - - - - - - - 0.00 23 350
Accounts Receivable
590 615 693 774 914 881 888 995 1,116 1,199 1,241
Prepaid Expenses
154 189 236 212 170 187 134 138 192 210 212
Plant, Property, & Equipment, net
175 193 207 213 254 231 215 181 190 208 190
Total Noncurrent Assets
1,423 1,466 1,809 1,962 2,648 2,894 2,839 2,629 2,724 2,699 2,996
Goodwill
1,038 1,069 1,337 1,394 1,574 1,696 1,731 1,684 1,684 1,670 1,781
Intangible Assets
99 79 132 177 231 237 170 90 53 27 67
Noncurrent Deferred & Refundable Income Taxes
99 70 77 75 90 107 106 135 299 269 259
Other Noncurrent Operating Assets
180 242 262 315 753 854 832 719 689 733 890
Total Liabilities & Shareholders' Equity
2,793 2,886 3,450 3,529 4,454 4,874 4,975 4,589 4,806 4,987 5,843
Total Liabilities
1,489 1,595 2,021 2,125 2,765 3,039 3,078 2,763 2,557 2,598 3,294
Total Current Liabilities
594 731 839 976 910 1,203 1,309 1,103 1,318 964 1,602
Short-Term Debt
61 199 209 328 104 284 383 177 442 26 376
Accounts Payable
10 9.77 15 43 22 14 25 36 28 36 28
Current Deferred & Payable Income Tax Liabilities
24 24 30 34 43 42 47 45 38 35 43
Other Current Liabilities
500 498 584 571 742 863 853 845 809 866 1,156
Total Noncurrent Liabilities
895 863 1,182 1,149 1,855 1,837 1,769 1,659 1,239 1,634 1,691
Long-Term Debt
737 698 1,007 976 1,340 1,307 1,272 1,249 825 1,195 1,166
Noncurrent Deferred & Payable Income Tax Liabilities
2.09 2.42 6.75 8.08 3.99 1.52 3.94 4.18 12 16 21
Other Noncurrent Operating Liabilities
155 163 169 165 511 528 493 406 403 423 504
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,304 1,287 1,424 1,404 1,689 1,834 1,897 1,826 2,248 2,390 2,549
Total Preferred & Common Equity
1,304 1,287 1,424 1,404 1,689 1,834 1,897 1,826 2,248 2,390 2,549
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,304 1,287 1,424 1,404 1,689 1,834 1,897 1,826 2,248 2,390 2,549
Common Stock
1,344 1,386 1,423 1,473 1,572 1,638 1,719 1,779 1,886 1,947 2,021
Retained Earnings
412 358 356 438 649 742 732 780 1,085 1,237 1,390
Accumulated Other Comprehensive Income / (Loss)
-451 -458 -355 -507 -532 -545 -554 -733 -723 -794 -861

Quarterly Balance Sheets for Genpact

This table presents Genpact's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025
Total Assets
4,537 4,506 4,482 4,599 4,741 5,178 5,326 4,895 5,308 5,364
Total Current Assets
1,758 1,734 1,748 1,870 1,830 2,266 2,401 1,943 2,135 2,212
Cash & Equivalents
519 552 491 541 478 914 1,023 562 663 741
Short-Term Investments
- - - - - - - 0.00 0.00 0.00
Accounts Receivable
994 1,005 1,008 1,054 1,147 1,160 1,214 1,192 1,267 1,281
Prepaid Expenses
230 176 249 274 205 192 164 189 205 191
Plant, Property, & Equipment, net
180 179 180 180 194 200 208 211 219 181
Total Noncurrent Assets
2,598 2,593 2,554 2,550 2,716 2,713 2,717 2,741 2,953 2,971
Goodwill
1,681 1,687 1,685 1,678 1,680 1,678 1,683 1,673 1,794 1,784
Intangible Assets
101 80 71 62 46 40 33 23 77 71
Noncurrent Deferred & Refundable Income Taxes
112 131 131 138 282 277 289 258 244 254
Other Noncurrent Operating Assets
704 695 667 672 708 718 712 788 838 862
Total Liabilities & Shareholders' Equity
4,537 4,506 4,482 4,599 4,741 5,178 5,326 4,895 5,308 5,364
Total Liabilities
2,805 2,581 2,549 2,589 2,442 2,841 2,931 2,442 2,721 2,820
Total Current Liabilities
1,633 945 931 979 1,185 1,198 1,295 792 1,392 1,462
Short-Term Debt
735 206 129 81 476 426 426 26 461 376
Accounts Payable
28 23 42 27 28 28 19 37 44 35
Current Deferred & Payable Income Tax Liabilities
107 64 94 131 39 44 53 40 56 54
Other Current Liabilities
754 652 667 740 642 700 797 688 832 997
Total Noncurrent Liabilities
1,172 1,636 1,618 1,610 1,257 1,643 1,636 1,650 1,329 1,358
Long-Term Debt
747 1,243 1,237 1,230 818 1,208 1,201 1,189 833 827
Noncurrent Deferred & Payable Income Tax Liabilities
3.63 4.49 3.79 3.82 12 10 12 16 17 16
Other Noncurrent Operating Liabilities
421 389 378 376 427 425 423 445 478 514
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,732 1,925 1,933 2,009 2,298 2,338 2,395 2,453 2,587 2,545
Total Preferred & Common Equity
1,732 1,925 1,933 2,009 2,298 2,338 2,395 2,453 2,587 2,545
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,732 1,925 1,933 2,009 2,298 2,338 2,395 2,453 2,587 2,545
Common Stock
1,742 1,797 1,833 1,858 1,881 1,902 1,924 1,943 1,967 1,993
Retained Earnings
745 831 801 894 1,145 1,176 1,207 1,275 1,347 1,374
Accumulated Other Comprehensive Income / (Loss)
-755 -702 -701 -742 -727 -740 -736 -765 -727 -822

Annual Metrics And Ratios for Genpact

This table displays calculated financial ratios and metrics derived from Genpact's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
7.97% 4.46% 6.46% 9.64% 17.32% 5.36% 8.43% 8.68% 2.42% 6.48% 6.56%
EBITDA Growth
20.06% -0.77% 3.86% 11.72% 13.13% 6.65% 15.25% -7.87% 16.45% 8.81% 6.60%
EBIT Growth
21.16% 2.82% 0.94% 11.85% 10.96% 1.48% 18.94% -3.20% 25.65% 11.36% 7.69%
NOPAT Growth
17.32% 4.27% -2.67% 0.35% 21.17% 3.04% 15.26% -2.00% 73.36% -19.42% 6.54%
Net Income Growth
24.79% 11.56% -2.51% 115.95% -45.87% 1.11% 19.84% -4.34% 78.62% -18.63% 7.56%
EPS Growth
28.24% 17.43% 4.69% 8.21% 7.59% 0.64% 21.66% -1.57% 81.38% -16.42% 9.82%
Operating Cash Flow Growth
20.45% 5.60% 3.85% -5.45% 26.03% 36.56% 18.82% -36.10% 10.63% 25.39% 32.08%
Free Cash Flow Firm Growth
693.80% -30.87% -167.71% 165.08% -97.95% 17,755.38% 85.90% -10.62% -21.91% 56.61% 17.94%
Invested Capital Growth
2.07% 7.07% 21.48% 9.34% 13.95% 2.98% -3.32% -1.81% 12.51% 0.26% -1.75%
Revenue Q/Q Growth
1.86% 1.39% 1.96% 3.48% 3.09% 0.27% 3.12% 0.70% 0.99% 2.20% 1.41%
EBITDA Q/Q Growth
-1.43% 3.47% -1.29% 5.61% 2.91% -1.30% 0.95% 1.47% 4.09% 2.65% 1.00%
EBIT Q/Q Growth
-1.57% 4.06% -3.07% 7.22% 1.89% -2.83% 1.09% 4.36% 5.31% 3.16% 0.92%
NOPAT Q/Q Growth
3.73% 5.32% -6.97% 9.39% 1.10% -0.33% -1.44% 3.84% 46.41% -22.25% 0.06%
Net Income Q/Q Growth
8.44% 4.55% -3.67% 109.98% -47.78% -2.29% -0.51% 4.94% 46.92% -22.53% 0.21%
EPS Q/Q Growth
9.00% 5.79% -2.19% 5.07% 0.65% -2.48% 0.00% 5.62% 46.98% -21.27% 0.64%
Operating Cash Flow Q/Q Growth
-5.53% 11.59% -3.85% 13.86% -10.49% 14.17% 14.46% -3.73% -7.14% 1.88% 11.44%
Free Cash Flow Firm Q/Q Growth
-25.81% 21.95% -93.99% -35.59% -99.18% 73.09% 78.96% 14.83% -6.70% 12.73% 10.54%
Invested Capital Q/Q Growth
1.79% 0.80% 2.22% 4.88% 12.07% 6.89% -1.51% -3.05% 5.46% -2.00% -3.95%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
39.31% 39.54% 38.56% 35.96% 34.82% 34.81% 35.60% 35.15% 35.08% 35.45% 36.04%
EBITDA Margin
17.89% 16.99% 16.58% 16.89% 16.29% 16.49% 17.52% 14.85% 16.89% 17.26% 17.26%
Operating Margin
13.58% 13.27% 12.10% 11.60% 12.20% 11.83% 12.65% 11.49% 14.09% 14.73% 14.77%
EBIT Margin
13.97% 13.75% 13.04% 13.30% 12.58% 12.12% 13.29% 11.84% 14.52% 15.19% 15.35%
Profit (Net Income) Margin
9.74% 10.41% 9.53% 18.77% 8.66% 8.31% 9.19% 8.08% 14.10% 10.78% 10.88%
Tax Burden Percent
79.47% 81.16% 81.36% 155.59% 76.33% 76.98% 76.47% 75.96% 104.82% 75.89% 75.67%
Interest Burden Percent
87.76% 93.24% 89.83% 90.70% 90.18% 89.11% 90.38% 89.91% 92.63% 93.48% 93.64%
Effective Tax Rate
20.53% 18.84% 18.64% 22.31% 23.67% 23.02% 23.53% 24.04% -4.82% 24.11% 24.33%
Return on Invested Capital (ROIC)
16.31% 16.26% 13.82% 12.08% 13.10% 12.48% 14.42% 14.51% 23.88% 18.15% 19.48%
ROIC Less NNEP Spread (ROIC-NNEP)
8.58% 13.95% 12.35% 47.67% 10.71% 9.36% 12.05% 10.85% 19.78% 15.04% 16.07%
Return on Net Nonoperating Assets (RNNOA)
2.21% 4.35% 5.36% 27.69% 6.61% 5.01% 5.38% 4.48% 7.10% 4.00% 2.89%
Return on Equity (ROE)
18.52% 20.62% 19.18% 39.77% 19.71% 17.50% 19.80% 18.98% 30.99% 22.15% 22.37%
Cash Return on Invested Capital (CROIC)
14.27% 9.43% -5.58% 3.16% 0.06% 9.55% 17.80% 16.33% 12.11% 17.89% 21.25%
Operating Return on Assets (OROA)
12.42% 12.45% 11.27% 11.44% 11.10% 9.64% 10.86% 10.82% 13.84% 14.79% 14.40%
Return on Assets (ROA)
8.66% 9.42% 8.23% 16.14% 7.64% 6.61% 7.50% 7.39% 13.44% 10.49% 10.20%
Return on Common Equity (ROCE)
18.52% 20.58% 19.11% 39.70% 19.71% 17.50% 19.80% 18.98% 30.99% 22.15% 22.37%
Return on Equity Simple (ROE_SIMPLE)
18.39% 20.79% 18.32% 40.11% 18.05% 16.81% 19.47% 19.35% 28.08% 21.50% 0.00%
Net Operating Profit after Tax (NOPAT)
266 277 270 270 328 338 389 381 661 533 568
NOPAT Margin
10.79% 10.77% 9.85% 9.01% 9.31% 9.10% 9.68% 8.73% 14.77% 11.18% 11.17%
Net Nonoperating Expense Percent (NNEP)
7.73% 2.32% 1.47% -35.59% 2.39% 3.12% 2.37% 3.65% 4.10% 3.11% 3.42%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 11.73% 18.81% 14.76% 13.87%
Cost of Revenue to Revenue
60.69% 60.46% 61.44% 64.04% 65.18% 65.19% 64.40% 64.85% 64.92% 64.55% 63.96%
SG&A Expenses to Revenue
24.71% 25.40% 25.19% 23.12% 22.58% 21.29% 21.52% 21.47% 20.40% 20.29% 20.61%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
25.73% 26.27% 26.46% 24.36% 22.62% 22.98% 22.95% 23.66% 20.99% 20.73% 21.28%
Earnings before Interest and Taxes (EBIT)
344 354 357 399 443 449 535 517 650 724 780
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
440 437 454 507 573 612 705 649 756 823 877
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.75 3.50 4.00 3.43 4.49 4.09 5.08 4.51 2.76 3.17 3.16
Price to Tangible Book Value (P/TBV)
29.25 32.57 0.00 0.00 0.00 0.00 0.00 157.57 12.11 10.93 11.50
Price to Revenue (P/Rev)
1.99 1.75 2.08 1.61 2.16 2.02 2.40 1.88 1.38 1.59 1.59
Price to Earnings (P/E)
20.42 16.70 21.65 8.54 24.90 24.31 26.10 23.29 9.81 14.75 14.60
Dividend Yield
0.00% 0.00% 0.81% 1.18% 0.85% 0.99% 0.84% 1.11% 1.61% 1.42% 1.45%
Earnings Yield
4.90% 5.99% 4.62% 11.71% 4.02% 4.11% 3.83% 4.29% 10.19% 6.78% 6.85%
Enterprise Value to Invested Capital (EV/IC)
3.18 2.83 3.00 2.46 3.21 3.06 3.92 3.46 2.35 2.76 2.91
Enterprise Value to Revenue (EV/Rev)
2.13 1.94 2.34 1.92 2.43 2.27 2.59 2.06 1.54 1.70 1.65
Enterprise Value to EBITDA (EV/EBITDA)
11.90 11.40 14.13 11.35 14.94 13.75 14.75 13.88 9.10 9.88 9.58
Enterprise Value to EBIT (EV/EBIT)
15.23 14.08 17.97 14.41 19.34 18.70 19.45 17.42 10.58 11.22 10.78
Enterprise Value to NOPAT (EV/NOPAT)
19.72 17.98 23.79 21.27 26.14 24.89 26.71 23.63 10.40 15.25 14.80
Enterprise Value to Operating Cash Flow (EV/OCF)
15.99 14.40 17.86 16.94 20.02 14.39 14.98 20.31 14.01 13.20 10.34
Enterprise Value to Free Cash Flow (EV/FCFF)
22.54 31.00 0.00 81.30 5,919.40 32.53 21.65 20.99 20.52 15.47 13.57
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.61 0.70 0.85 0.93 0.85 0.87 0.87 0.78 0.56 0.51 0.61
Long-Term Debt to Equity
0.57 0.54 0.70 0.69 0.79 0.71 0.67 0.68 0.37 0.50 0.46
Financial Leverage
0.26 0.31 0.43 0.58 0.62 0.54 0.45 0.41 0.36 0.27 0.18
Leverage Ratio
2.14 2.19 2.33 2.46 2.58 2.65 2.64 2.57 2.31 2.11 2.19
Compound Leverage Factor
1.88 2.04 2.09 2.23 2.33 2.36 2.39 2.31 2.14 1.97 2.05
Debt to Total Capital
37.96% 41.00% 45.98% 48.15% 46.08% 46.45% 46.61% 43.85% 36.04% 33.83% 37.69%
Short-Term Debt to Total Capital
2.88% 9.10% 7.91% 12.13% 3.30% 8.28% 10.79% 5.45% 12.58% 0.72% 9.19%
Long-Term Debt to Total Capital
35.07% 31.90% 38.06% 36.02% 42.77% 38.17% 35.81% 38.41% 23.46% 33.10% 28.50%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.21% 0.18% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
62.04% 58.79% 53.85% 51.85% 53.92% 53.55% 53.39% 56.15% 63.96% 66.17% 62.31%
Debt to EBITDA
1.81 2.05 2.68 2.57 2.52 2.60 2.35 2.20 1.68 1.48 1.76
Net Debt to EBITDA
0.77 1.08 1.57 1.84 1.70 1.49 1.07 1.20 0.90 0.67 0.39
Long-Term Debt to EBITDA
1.68 1.60 2.22 1.92 2.34 2.14 1.81 1.92 1.09 1.45 1.33
Debt to NOPAT
3.00 3.24 4.51 4.82 4.40 4.71 4.25 3.74 1.92 2.29 2.72
Net Debt to NOPAT
1.28 1.70 2.64 3.46 2.98 2.70 1.94 2.04 1.03 1.03 0.60
Long-Term Debt to NOPAT
2.78 2.52 3.73 3.61 4.09 3.87 3.27 3.27 1.25 2.24 2.05
Altman Z-Score
3.72 3.37 3.18 2.89 3.14 2.89 3.40 3.53 3.29 3.80 3.33
Noncontrolling Interest Sharing Ratio
0.00% 0.17% 0.34% 0.17% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.01 1.68 1.71 1.39 1.70 1.45 1.47 1.61 1.44 2.16 1.66
Quick Ratio
1.75 1.42 1.43 1.17 1.52 1.30 1.37 1.49 1.29 1.94 1.53
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
232 161 -109 71 1.45 258 480 429 335 525 619
Operating Cash Flow to CapEx
539.56% 424.89% 647.07% 402.69% 584.73% 839.97% 1,478.55% 877.62% 886.01% 768.02% 1,040.20%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.89 0.91 0.86 0.86 0.88 0.80 0.82 0.91 0.95 0.97 0.94
Accounts Receivable Turnover
4.41 4.27 4.18 4.09 4.17 4.13 4.55 4.64 4.24 4.12 4.17
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
14.01 13.95 13.68 14.30 15.09 15.29 18.03 22.09 24.16 23.97 25.50
Accounts Payable Turnover
116.55 156.58 135.50 66.69 71.08 134.75 133.20 93.26 91.47 95.85 101.52
Days Sales Outstanding (DSO)
82.75 85.57 87.24 89.24 87.53 88.33 80.25 78.60 86.06 88.62 87.63
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
3.13 2.33 2.69 5.47 5.14 2.71 2.74 3.91 3.99 3.81 3.60
Cash Conversion Cycle (CCC)
79.62 83.24 84.55 83.76 82.39 85.62 77.51 74.68 82.07 84.81 84.03
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,645 1,761 2,139 2,339 2,665 2,745 2,654 2,606 2,932 2,939 2,888
Invested Capital Turnover
1.51 1.51 1.40 1.34 1.41 1.37 1.49 1.66 1.62 1.62 1.74
Increase / (Decrease) in Invested Capital
33 116 378 200 326 79 -91 -48 326 7.76 -52
Enterprise Value (EV)
5,237 4,978 6,412 5,752 8,566 8,406 10,398 9,012 6,878 8,125 8,404
Market Capitalization
4,897 4,504 5,697 4,817 7,590 7,495 9,642 8,232 6,195 7,575 8,066
Book Value per Share
$6.13 $6.41 $7.38 $7.39 $8.89 $9.69 $10.09 $9.96 $12.39 $13.55 $14.79
Tangible Book Value per Share
$0.79 $0.69 ($0.23) ($0.88) ($0.61) ($0.52) ($0.02) $0.29 $2.82 $3.93 $4.07
Total Capital
2,102 2,189 2,645 2,708 3,132 3,425 3,553 3,252 3,515 3,611 4,092
Total Debt
798 897 1,216 1,304 1,443 1,591 1,656 1,426 1,267 1,221 1,542
Total Long-Term Debt
737 698 1,007 976 1,340 1,307 1,272 1,249 825 1,195 1,166
Net Debt
340 470 711 935 976 910 756 780 683 550 338
Capital Expenditures (CapEx)
61 81 55 84 73 70 47 51 55 80 78
Debt-free, Cash-free Net Working Capital (DFCFNWC)
210 272 300 339 278 149 97 207 432 471 226
Debt-free Net Working Capital (DFNWC)
661 695 804 707 745 830 996 853 1,016 1,143 1,430
Net Working Capital (NWC)
601 496 595 379 641 546 613 676 574 1,116 1,054
Net Nonoperating Expense (NNE)
26 9.38 8.70 -293 23 29 20 28 30 19 15
Net Nonoperating Obligations (NNO)
340 470 711 935 976 910 756 780 683 550 338
Total Depreciation and Amortization (D&A)
96 83 97 108 130 162 170 132 106 99 97
Debt-free, Cash-free Net Working Capital to Revenue
8.55% 10.59% 10.96% 11.29% 7.89% 4.03% 2.41% 4.73% 9.65% 9.88% 4.45%
Debt-free Net Working Capital to Revenue
26.87% 27.03% 29.39% 23.57% 21.16% 22.37% 24.77% 19.52% 22.69% 23.97% 28.15%
Net Working Capital to Revenue
24.40% 19.28% 21.74% 12.62% 18.22% 14.73% 15.24% 15.47% 12.81% 23.42% 20.75%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.11 $1.30 $1.36 $1.48 $1.60 $1.62 $1.97 $1.92 $3.46 $2.88 $3.18
Adjusted Weighted Average Basic Shares Outstanding
216.61M 206.86M 193.86M 190.67M 190.07M 190.40M 187.80M 184.18M 182.35M 178.39M 173.89M
Adjusted Diluted Earnings per Share
$1.09 $1.28 $1.34 $1.45 $1.56 $1.57 $1.91 $1.88 $3.41 $2.85 $3.13
Adjusted Weighted Average Diluted Shares Outstanding
219.15M 210.13M 197.05M 193.98M 195.16M 195.78M 192.96M 188.09M 185.14M 180.44M 176.65M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
210.55M 198.97M 193.48M 189.46M 190.40M 188.14M 185.17M 183.98M 180.73M 175.67M 169.86M
Normalized Net Operating Profit after Tax (NOPAT)
266 277 270 270 328 338 389 381 442 533 568
Normalized NOPAT Margin
10.79% 10.77% 9.85% 9.01% 9.31% 9.10% 9.68% 8.73% 9.86% 11.18% 11.17%
Pre Tax Income Margin
12.26% 12.82% 11.71% 12.06% 11.35% 10.80% 12.01% 10.64% 13.45% 14.20% 14.37%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 17.90% 10.14% 21.21% 24.07% 21.78% 25.99% 15.84% 21.12% 21.31%
Augmented Payout Ratio
94.70% 129.13% 102.16% 37.51% 31.06% 68.55% 102.50% 86.56% 51.57% 70.31% 21.31%

Quarterly Metrics And Ratios for Genpact

This table displays calculated financial ratios and metrics derived from Genpact's official financial filings.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
1.50% 2.23% 3.96% 3.85% 6.39% 6.62% 8.94% 7.40% 6.65% 6.63% 5.65%
EBITDA Growth
34.24% 16.74% 17.73% 8.94% 5.80% 9.63% 10.76% 8.95% 5.97% 7.78% 3.98%
EBIT Growth
52.49% 25.05% 23.63% 12.50% 8.27% 11.72% 12.96% 12.04% 8.11% 7.59% 3.68%
NOPAT Growth
47.55% 21.44% 221.35% 7.61% 5.14% 9.30% -50.58% 14.65% 5.35% 7.36% 0.18%
Net Income Growth
62.20% 22.69% 224.72% 10.22% 4.94% 12.95% -51.28% 11.89% 8.79% 9.80% 0.83%
EPS Growth
65.79% 25.49% 227.08% 12.28% 6.35% 15.63% -49.04% 14.06% 11.94% 12.16% 2.50%
Operating Cash Flow Growth
67.54% -28.53% -16.43% 24.96% 22.06% 41.44% 5.91% 258.19% -15.25% 34.97% 41.06%
Free Cash Flow Firm Growth
108.88% -69.61% -119.06% -199.80% -216.35% -345.14% 621.41% 183.88% 78.99% 271.20% 42.56%
Invested Capital Growth
0.60% 3.43% 12.51% 10.35% 8.90% 7.90% 0.26% -0.24% 5.24% 0.24% -1.75%
Revenue Q/Q Growth
1.49% 2.74% 0.92% -1.31% 3.98% 2.95% 3.12% -2.71% 3.25% 2.94% 2.17%
EBITDA Q/Q Growth
7.83% 2.31% 1.93% -3.12% 4.71% 6.01% 2.98% -4.70% 1.85% 7.82% -0.65%
EBIT Q/Q Growth
9.73% 3.48% 1.92% -2.79% 5.61% 6.77% 3.05% -3.58% 1.90% 6.26% -0.70%
NOPAT Q/Q Growth
9.39% 3.42% 137.82% -60.00% 6.87% 7.51% 7.54% -7.21% -1.80% 9.56% 0.35%
Net Income Q/Q Growth
9.57% 1.15% 147.73% -59.85% 4.31% 8.88% 6.85% -7.79% 1.42% 9.88% -1.88%
EPS Q/Q Growth
10.53% 1.59% 145.31% -59.24% 4.69% 10.45% 8.11% -8.75% 2.74% 10.67% -1.20%
Operating Cash Flow Q/Q Growth
603.31% -5.79% 18.81% -113.32% 918.72% 9.17% -11.04% -80.11% 338.63% 73.86% -7.03%
Free Cash Flow Firm Q/Q Growth
-39.33% -68.05% -180.27% -541.39% 29.27% 32.68% 270.73% 3.19% -117.71% 648.57% 42.17%
Invested Capital Q/Q Growth
-0.52% -0.97% 5.46% 6.22% -1.83% -1.88% -2.00% 5.69% 3.56% -6.55% -3.95%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
35.28% 35.47% 35.56% 35.05% 35.40% 35.63% 35.70% 35.31% 35.88% 36.37% 36.56%
EBITDA Margin
17.13% 17.06% 17.23% 16.91% 17.03% 17.54% 17.51% 17.16% 16.92% 17.73% 17.24%
Operating Margin
14.23% 14.59% 14.20% 14.14% 14.47% 15.00% 15.23% 15.12% 14.30% 14.84% 14.82%
EBIT Margin
14.70% 14.81% 14.95% 14.73% 14.96% 15.51% 15.50% 15.36% 15.16% 15.65% 15.21%
Profit (Net Income) Margin
10.52% 10.35% 25.41% 10.34% 10.37% 10.97% 11.36% 10.77% 10.58% 11.29% 10.85%
Tax Burden Percent
77.31% 75.91% 183.82% 74.79% 75.11% 75.69% 77.74% 74.68% 75.09% 77.02% 75.78%
Interest Burden Percent
92.53% 92.12% 92.46% 93.85% 92.31% 93.41% 94.29% 93.87% 92.91% 93.68% 94.08%
Effective Tax Rate
22.69% 24.09% -83.82% 25.21% 24.89% 24.31% 22.26% 25.32% 24.91% 22.98% 24.22%
Return on Invested Capital (ROIC)
17.33% 17.96% 42.20% 16.10% 17.02% 18.33% 19.23% 17.61% 16.87% 19.07% 19.57%
ROIC Less NNEP Spread (ROIC-NNEP)
16.77% 17.01% 41.13% 15.79% 16.28% 17.65% 18.26% 16.75% 16.58% 18.74% 18.44%
Return on Net Nonoperating Assets (RNNOA)
8.72% 7.85% 14.77% 6.40% 6.08% 5.51% 4.86% 5.18% 4.55% 4.05% 3.32%
Return on Equity (ROE)
26.04% 25.81% 56.96% 22.50% 23.09% 23.84% 24.08% 22.79% 21.42% 23.11% 22.89%
Cash Return on Invested Capital (CROIC)
14.74% 13.14% 12.11% 12.69% 14.50% 16.12% 17.89% 17.93% 12.65% 18.65% 21.25%
Operating Return on Assets (OROA)
14.36% 14.37% 14.25% 14.40% 14.21% 14.58% 15.09% 15.47% 14.26% 14.67% 14.27%
Return on Assets (ROA)
10.28% 10.05% 24.22% 10.10% 9.85% 10.31% 11.06% 10.84% 9.95% 10.58% 10.17%
Return on Common Equity (ROCE)
26.04% 25.81% 56.96% 22.50% 23.09% 23.84% 24.08% 22.79% 21.42% 23.11% 22.89%
Return on Equity Simple (ROE_SIMPLE)
21.10% 21.38% 0.00% 27.94% 27.71% 27.69% 0.00% 21.51% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
122 126 299 120 128 137 148 137 135 148 148
NOPAT Margin
11.00% 11.07% 26.10% 10.58% 10.87% 11.35% 11.84% 11.29% 10.74% 11.43% 11.23%
Net Nonoperating Expense Percent (NNEP)
0.56% 0.95% 1.07% 0.32% 0.74% 0.68% 0.96% 0.86% 0.30% 0.33% 1.13%
Return On Investment Capital (ROIC_SIMPLE)
- - 8.51% - - - 4.09% 3.74% 3.47% 3.94% 3.62%
Cost of Revenue to Revenue
64.72% 64.53% 64.44% 64.95% 64.60% 64.37% 64.30% 64.69% 64.12% 63.63% 63.44%
SG&A Expenses to Revenue
20.75% 20.23% 20.71% 20.78% 20.37% 20.09% 19.95% 19.84% 21.24% 20.30% 21.01%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
21.05% 20.88% 21.36% 20.91% 20.93% 20.63% 20.47% 20.19% 21.58% 21.53% 21.74%
Earnings before Interest and Taxes (EBIT)
163 168 171 167 176 188 194 187 190 202 201
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
189 194 197 191 200 212 219 208 212 229 227
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.52 3.21 2.76 2.58 2.48 2.92 3.17 3.61 2.98 2.87 3.16
Price to Tangible Book Value (P/TBV)
38.44 23.92 12.11 10.36 9.34 10.30 10.93 11.69 10.76 10.59 11.50
Price to Revenue (P/Rev)
1.54 1.46 1.38 1.31 1.26 1.50 1.59 1.82 1.56 1.46 1.59
Price to Earnings (P/E)
16.68 15.02 9.81 9.23 8.94 10.54 14.75 16.78 14.30 13.24 14.60
Dividend Yield
1.42% 1.51% 1.61% 1.72% 1.80% 1.52% 1.42% 1.25% 1.47% 1.58% 1.45%
Earnings Yield
6.00% 6.66% 10.19% 10.83% 11.18% 9.49% 6.78% 5.96% 6.99% 7.55% 6.85%
Enterprise Value to Invested Capital (EV/IC)
2.74 2.60 2.35 2.17 2.13 2.53 2.76 3.06 2.59 2.58 2.91
Enterprise Value to Revenue (EV/Rev)
1.74 1.63 1.54 1.49 1.42 1.63 1.70 1.96 1.69 1.55 1.65
Enterprise Value to EBITDA (EV/EBITDA)
10.99 9.95 9.10 8.74 8.32 9.47 9.88 11.32 9.78 8.94 9.58
Enterprise Value to EBIT (EV/EBIT)
13.15 11.70 10.58 10.09 9.55 10.82 11.22 12.77 10.98 10.05 10.78
Enterprise Value to NOPAT (EV/NOPAT)
17.88 15.99 10.40 10.09 9.65 11.08 15.25 17.27 14.94 13.68 14.80
Enterprise Value to Operating Cash Flow (EV/OCF)
12.95 13.67 14.01 13.51 12.13 12.57 13.20 13.95 12.82 10.64 10.34
Enterprise Value to Free Cash Flow (EV/FCFF)
18.62 20.10 20.52 17.90 15.32 16.30 15.47 17.04 20.98 13.86 13.57
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.71 0.65 0.56 0.56 0.70 0.68 0.51 0.50 0.50 0.47 0.61
Long-Term Debt to Equity
0.64 0.61 0.37 0.36 0.52 0.50 0.50 0.48 0.32 0.33 0.46
Financial Leverage
0.52 0.46 0.36 0.41 0.37 0.31 0.27 0.31 0.27 0.22 0.18
Leverage Ratio
2.45 2.44 2.31 2.19 2.26 2.25 2.11 2.03 2.13 2.16 2.19
Compound Leverage Factor
2.27 2.25 2.13 2.05 2.09 2.10 1.99 1.90 1.98 2.03 2.06
Debt to Total Capital
41.40% 39.49% 36.04% 36.02% 41.13% 40.46% 33.83% 33.13% 33.35% 32.10% 37.69%
Short-Term Debt to Total Capital
3.92% 2.44% 12.58% 13.24% 10.72% 10.59% 0.72% 0.71% 11.87% 10.03% 9.19%
Long-Term Debt to Total Capital
37.49% 37.05% 23.46% 22.78% 30.41% 29.87% 33.10% 32.41% 21.47% 22.07% 28.50%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
58.60% 60.51% 63.96% 63.98% 58.87% 59.54% 66.17% 66.87% 66.65% 67.90% 62.31%
Debt to EBITDA
1.96 1.81 1.68 1.68 2.09 2.03 1.48 1.45 1.52 1.39 1.76
Net Debt to EBITDA
1.25 1.06 0.90 1.06 0.92 0.75 0.67 0.78 0.74 0.53 0.39
Long-Term Debt to EBITDA
1.77 1.69 1.09 1.06 1.54 1.50 1.45 1.42 0.98 0.95 1.33
Debt to NOPAT
3.18 2.90 1.92 1.94 2.42 2.37 2.29 2.21 2.32 2.12 2.72
Net Debt to NOPAT
2.04 1.71 1.03 1.22 1.07 0.88 1.03 1.19 1.13 0.81 0.60
Long-Term Debt to NOPAT
2.88 2.72 1.25 1.22 1.79 1.75 2.24 2.16 1.50 1.46 2.05
Altman Z-Score
3.17 3.08 2.96 3.03 2.79 2.99 3.45 3.94 3.27 3.14 3.00
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.88 1.91 1.44 1.54 1.89 1.85 2.16 2.45 1.53 1.51 1.66
Quick Ratio
1.61 1.63 1.29 1.37 1.73 1.73 1.94 2.22 1.39 1.38 1.53
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
105 33 -27 -172 -122 -82 140 145 -26 140 200
Operating Cash Flow to CapEx
1,497.74% 1,215.11% 1,061.02% -106.48% 1,092.53% 1,156.14% 1,180.98% 183.98% 798.15% 1,890.04% 1,623.60%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.98 0.97 0.95 0.98 0.95 0.94 0.97 1.01 0.94 0.94 0.94
Accounts Receivable Turnover
4.36 4.33 4.24 4.20 4.23 4.11 4.12 4.15 4.06 4.02 4.17
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
23.90 24.62 24.16 24.23 24.20 24.09 23.97 23.98 23.53 25.81 25.50
Accounts Payable Turnover
83.26 105.70 91.47 115.16 84.29 133.39 95.85 95.79 87.67 120.63 101.52
Days Sales Outstanding (DSO)
83.71 84.34 86.06 86.94 86.19 88.76 88.62 88.01 89.84 90.90 87.63
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
4.38 3.45 3.99 3.17 4.33 2.74 3.81 3.81 4.16 3.03 3.60
Cash Conversion Cycle (CCC)
79.32 80.89 82.07 83.77 81.86 86.02 84.81 84.20 85.68 87.87 84.03
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,807 2,780 2,932 3,114 3,057 3,000 2,939 3,107 3,217 3,007 2,888
Invested Capital Turnover
1.58 1.62 1.62 1.52 1.57 1.61 1.62 1.56 1.57 1.67 1.74
Increase / (Decrease) in Invested Capital
17 92 326 292 250 220 7.76 -7.36 160 7.13 -52
Enterprise Value (EV)
7,678 7,224 6,878 6,744 6,513 7,591 8,125 9,504 8,327 7,762 8,404
Market Capitalization
6,804 6,453 6,195 5,928 5,794 6,986 7,575 8,850 7,696 7,300 8,066
Book Value per Share
$10.50 $11.08 $12.39 $12.72 $12.99 $13.44 $13.55 $13.96 $14.79 $14.60 $14.79
Tangible Book Value per Share
$0.96 $1.49 $2.82 $3.17 $3.45 $3.81 $3.93 $4.31 $4.09 $3.96 $4.07
Total Capital
3,299 3,321 3,515 3,592 3,971 4,022 3,611 3,668 3,881 3,747 4,092
Total Debt
1,366 1,312 1,267 1,294 1,634 1,628 1,221 1,215 1,294 1,203 1,542
Total Long-Term Debt
1,237 1,230 825 818 1,208 1,201 1,195 1,189 833 827 1,166
Net Debt
875 771 683 816 719 605 550 654 631 462 338
Capital Expenditures (CapEx)
11 13 18 24 19 20 17 22 22 16 18
Debt-free, Cash-free Net Working Capital (DFCFNWC)
455 431 432 642 580 510 471 616 540 386 226
Debt-free Net Working Capital (DFNWC)
946 972 1,016 1,121 1,494 1,532 1,143 1,177 1,203 1,127 1,430
Net Working Capital (NWC)
817 891 574 645 1,068 1,106 1,116 1,151 743 751 1,054
Net Nonoperating Expense (NNE)
5.37 8.19 7.83 2.71 5.88 4.66 5.93 6.33 2.00 1.76 5.02
Net Nonoperating Obligations (NNO)
875 771 683 816 719 605 550 654 631 462 338
Total Depreciation and Amortization (D&A)
27 26 26 25 24 24 25 22 22 27 27
Debt-free, Cash-free Net Working Capital to Revenue
10.31% 9.72% 9.65% 14.22% 12.64% 10.92% 9.88% 12.69% 10.96% 7.70% 4.45%
Debt-free Net Working Capital to Revenue
21.45% 21.92% 22.69% 24.80% 32.56% 32.85% 23.97% 24.27% 24.41% 22.49% 28.15%
Net Working Capital to Revenue
18.53% 20.09% 12.81% 14.27% 23.28% 23.71% 23.42% 23.73% 15.07% 14.99% 20.75%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.63 $0.65 $1.60 $0.65 $0.68 $0.75 $0.80 $0.75 $0.76 $0.84 $0.83
Adjusted Weighted Average Basic Shares Outstanding
183.23M 181.40M 182.35M 180.42M 179.65M 177.60M 178.39M 175.53M 174.61M 173.58M 173.89M
Adjusted Diluted Earnings per Share
$0.63 $0.64 $1.57 $0.64 $0.67 $0.74 $0.80 $0.73 $0.75 $0.83 $0.82
Adjusted Weighted Average Diluted Shares Outstanding
185.83M 183.80M 185.14M 181.94M 180.91M 179.71M 180.44M 178.44M 177.05M 176.10M 176.65M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
181.32M 181.41M 180.73M 179.98M 178.18M 176.36M 175.67M 174.87M 174.27M 172.41M 169.86M
Normalized Net Operating Profit after Tax (NOPAT)
122 126 114 120 128 137 148 137 135 148 148
Normalized NOPAT Margin
11.00% 11.07% 9.94% 10.58% 10.87% 11.35% 11.84% 11.29% 10.74% 11.43% 11.23%
Pre Tax Income Margin
13.60% 13.64% 13.83% 13.82% 13.81% 14.49% 14.62% 14.42% 14.09% 14.66% 14.31%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
23.55% 22.84% 15.84% 15.92% 16.14% 16.07% 21.12% 20.99% 21.00% 20.93% 21.31%
Augmented Payout Ratio
23.55% 22.84% 51.57% 15.92% 16.14% 16.07% 70.31% 20.99% 21.00% 20.93% 21.31%

Financials Breakdown Chart

Key Financial Trends

Genpact Ltd (NYSE: G) has shown a clear growth trajectory through 2022–2025 in the quarterly data you provided. 2025 stood out with continued revenue expansion, margin stability, and strong cash generation. The company also funded growth activities with debt but maintained solid profitability and cashflow generation. Below is a concise takeaway focused on the last four years, with the most relevant items for retail investors.

  • Revenue and earnings momentum in 2025: Operating revenue rose each quarter in 2025, culminating at about $1.32 billion in Q4 2025, up from roughly $1.22 billion in Q1 2025. Net income attributable to common shareholders and basic/diluted EPS also trended higher across the year (Q4 2025 EPS around $0.83–$0.84, with net income roughly $143 million for the quarter).
  • Gross margin stability and modest expansion: Gross margin stayed in the mid-30s throughout 2025 and edged higher toward 36–37% by Q4 2025, indicating efficient cost control relative to rising revenue.
  • Strong cash flow generation: Cash flow from continuing operating activities was robust in 2025 (e.g., Q3 2025 about $308 million; Q4 2025 around $287 million), and free cash flow remained positive after capex in the quarter, highlighting healthy internal cash generation.
  • Dividend policy and cash return to shareholders: Genpact continued paying a steady quarterly dividend of $0.17 per share across 2025, offering predictable income to investors.
  • Balance sheet position and liquidity: Total assets increased through 2025, with a solid cash balance (cash and equivalents typically well over $0.5–0.7 billion range in the period) and a growing equity base, supporting capacity to fund operations and moderate growth investments.
  • Debt usage and leverage: The company complemented revenue growth with debt issuance in 2025 (notably notable quarterly debt inflows), which supports expansion but adds leverage. The effect on leverage depends on future earnings and debt management, but cash flow coverage remains a key consideration for investors.
  • Operating expense dynamics: Selling, general & administrative (SG&A) expenses fluctuated modestly quarter to quarter but stayed in a range that allowed operating income to remain positive and rising as revenue grew.
  • Working capital volatility: Changes in operating assets and liabilities varied by quarter, contributing to fluctuations in cash flow from operations on a short-term basis, though annual cash generation remained solid.
  • Rising liability load and interest burden potential: Liability totals increased over 2025 due to debt issuance and higher current liabilities, which could pressure future interest costs and require continued strong profitability to maintain balance-sheet health.
  • Financing activities occasionally negative on a quarterly basis: Net cash from financing activities showed quarterly variability, including outflows for debt repayments and dividends in some periods, which can temper near-term cash build if not offset by operating cashflow.
05/07/26 02:01 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Genpact's Financials

When does Genpact's fiscal year end?

According to the most recent income statement we have on file, Genpact's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

How has Genpact's net income changed over the last 10 years?

Genpact's net income appears to be on an upward trend, with a most recent value of $552.49 million in 2025, rising from $239.82 million in 2015. The previous period was $513.67 million in 2024. See Genpact's forecast for analyst expectations on what’s next for the company.

What is Genpact's operating income?
Genpact's total operating income in 2025 was $750.21 million, based on the following breakdown:
  • Total Gross Profit: $1.83 billion
  • Total Operating Expenses: $1.08 billion
How has Genpact's revenue changed over the last 10 years?

Over the last 10 years, Genpact's total revenue changed from $2.46 billion in 2015 to $5.08 billion in 2025, a change of 106.4%.

How much debt does Genpact have?

Genpact's total liabilities were at $3.29 billion at the end of 2025, a 26.8% increase from 2024, and a 121.2% increase since 2015.

How much cash does Genpact have?

In the past 10 years, Genpact's cash and equivalents has ranged from $368.40 million in 2018 to $899.46 million in 2021, and is currently $853.84 million as of their latest financial filing in 2025.

How has Genpact's book value per share changed over the last 10 years?

Over the last 10 years, Genpact's book value per share changed from 6.13 in 2015 to 14.79 in 2025, a change of 141.1%.



Financial statements for NYSE:G last updated on 2/27/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners